These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

612 related articles for article (PubMed ID: 11125298)

  • 21. Blocking of the alpha interferon-induced Jak-Stat signaling pathway by Japanese encephalitis virus infection.
    Lin RJ; Liao CL; Lin E; Lin YL
    J Virol; 2004 Sep; 78(17):9285-94. PubMed ID: 15308723
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prolactin activates Stat1 but does not antagonize Stat1 activation and growth inhibition by type I interferons in human breast cancer cells.
    Schaber JD; Fang H; Xu J; Grimley PM; Rui H
    Cancer Res; 1998 May; 58(9):1914-9. PubMed ID: 9581833
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Affinity of Stat2 for the subunits of the interferon alpha receptor.
    Saleh AZ; Nguyen VP; Krolewski JJ
    Biochemistry; 2002 Sep; 41(37):11261-8. PubMed ID: 12220192
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The WD motif-containing protein RACK-1 functions as a scaffold protein within the type I IFN receptor-signaling complex.
    Usacheva A; Tian X; Sandoval R; Salvi D; Levy D; Colamonici OR
    J Immunol; 2003 Sep; 171(6):2989-94. PubMed ID: 12960323
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A monoclonal antibody to recombinant human IFN-alpha receptor inhibits biologic activity of several species of human IFN-alpha, IFN-beta, and IFN-omega. Detection of heterogeneity of the cellular type I IFN receptor.
    Benoit P; Maguire D; Plavec I; Kocher H; Tovey M; Meyer F
    J Immunol; 1993 Feb; 150(3):707-16. PubMed ID: 8423335
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The intracellular domain of interferon-alpha receptor 2c (IFN-alphaR2c) chain is responsible for Stat activation.
    Kotenko SV; Izotova LS; Mirochnitchenko OV; Lee C; Pestka S
    Proc Natl Acad Sci U S A; 1999 Apr; 96(9):5007-12. PubMed ID: 10220409
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mapping human interferon-alpha (IFN-alpha 2) binding determinants of the type I interferon receptor subunit IFNAR-1 with human/bovine IFNAR-1 chimeras.
    Goldman LA; Cutrone EC; Dang A; Hao X; Lim JK; Langer JA
    Biochemistry; 1998 Sep; 37(37):13003-10. PubMed ID: 9737881
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mutational analysis of the IFNAR1 binding site on IFNalpha2 reveals the architecture of a weak ligand-receptor binding-site.
    Roisman LC; Jaitin DA; Baker DP; Schreiber G
    J Mol Biol; 2005 Oct; 353(2):271-81. PubMed ID: 16171819
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Characterization of a domain of a human type I interferon receptor protein involved in ligand binding.
    Eid P; Tovey MG
    J Interferon Cytokine Res; 1995 Mar; 15(3):205-11. PubMed ID: 7584665
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inquiring into the differential action of interferons (IFNs): an IFN-alpha2 mutant with enhanced affinity to IFNAR1 is functionally similar to IFN-beta.
    Jaitin DA; Roisman LC; Jaks E; Gavutis M; Piehler J; Van der Heyden J; Uze G; Schreiber G
    Mol Cell Biol; 2006 Mar; 26(5):1888-97. PubMed ID: 16479007
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Identification of critical residues in bovine IFNAR-1 responsible for interferon binding.
    Cutrone EC; Langer JA
    J Biol Chem; 2001 May; 276(20):17140-8. PubMed ID: 11278538
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Differential tyrosine phosphorylation of the IFNAR chain of the type I interferon receptor and of an associated surface protein in response to IFN-alpha and IFN-beta.
    Abramovich C; Shulman LM; Ratovitski E; Harroch S; Tovey M; Eid P; Revel M
    EMBO J; 1994 Dec; 13(24):5871-7. PubMed ID: 7813427
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Distinct mechanisms of STAT phosphorylation via the interferon-alpha/beta receptor. Selective inhibition of STAT3 and STAT5 by piceatannol.
    Su L; David M
    J Biol Chem; 2000 Apr; 275(17):12661-6. PubMed ID: 10777558
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Functional cartography of the ectodomain of the type I interferon receptor subunit ifnar1.
    Lamken P; Gavutis M; Peters I; Van der Heyden J; Uzé G; Piehler J
    J Mol Biol; 2005 Jul; 350(3):476-88. PubMed ID: 15946680
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Enterovirus 71 inhibits cellular type I interferon signaling by downregulating JAK1 protein expression.
    Liu Y; Zhang Z; Zhao X; Yu R; Zhang X; Wu S; Liu J; Chi X; Song X; Fu L; Yu Y; Hou L; Chen W
    Viral Immunol; 2014 Aug; 27(6):267-76. PubMed ID: 24905060
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Molecular characterization of an alpha interferon receptor 1 subunit (IFNaR1) domain required for TYK2 binding and signal transduction.
    Yan H; Krishnan K; Lim JT; Contillo LG; Krolewski JJ
    Mol Cell Biol; 1996 May; 16(5):2074-82. PubMed ID: 8628273
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The role of the growth hormone (GH) receptor and JAK1 and JAK2 kinases in the activation of Stats 1, 3, and 5 by GH.
    Smit LS; Meyer DJ; Billestrup N; Norstedt G; Schwartz J; Carter-Su C
    Mol Endocrinol; 1996 May; 10(5):519-33. PubMed ID: 8732683
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A type I interferon autocrine-paracrine loop is involved in Toll-like receptor-induced interleukin-12p70 secretion by dendritic cells.
    Gautier G; Humbert M; Deauvieau F; Scuiller M; Hiscott J; Bates EE; Trinchieri G; Caux C; Garrone P
    J Exp Med; 2005 May; 201(9):1435-46. PubMed ID: 15851485
    [TBL] [Abstract][Full Text] [Related]  

  • 39. STAT3 activation by type I interferons is dependent on specific tyrosines located in the cytoplasmic domain of interferon receptor chain 2c. Activation of multiple STATS proceeds through the redundant usage of two tyrosine residues.
    Velichko S; Wagner TC; Turkson J; Jove R; Croze E
    J Biol Chem; 2002 Sep; 277(38):35635-41. PubMed ID: 12105218
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mechanisms of type I interferon signaling in normal and malignant cells.
    Li Y; Srivastava KK; Platanias LC
    Arch Immunol Ther Exp (Warsz); 2004; 52(3):156-63. PubMed ID: 15247882
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 31.